(90 days)
Not Found
No
The summary describes a physical medical device (biliary stent and insertion kit) and its intended use and testing, with no mention of software, algorithms, or AI/ML capabilities.
Yes
The device, a biliary drainage stent, is used to maintain the flow of bile, addressing a medical condition (biliary obstruction) and providing a therapeutic effect.
No
The device is a biliary stent intended for drainage, not for diagnosing a condition. It is used to maintain bile flow by physical indwelling.
No
The device description clearly outlines a physical medical device (stent, insertion kit, preloaded stent series) and its intended use in a physical procedure (ERBD). There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "endoscopic retrograde biliary drainage (ERBD)" and the device is a "biliary drainage stent." This describes a procedure performed on the patient's body to drain bile, not a test performed on a sample taken from the patient's body to diagnose a condition.
- Device Description: The description details a stent and insertion kit used to place the stent within the duodenal papilla to maintain bile flow. This is a therapeutic intervention, not a diagnostic test.
- Lack of Diagnostic Elements: There is no mention of analyzing samples (blood, urine, tissue, etc.), detecting analytes, or providing diagnostic information about a patient's condition.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device is a medical device used for a therapeutic procedure.
N/A
Intended Use / Indications for Use
This instrument has been designed to be used with Olympus Endoscopes for endoscopic retrograde biliary drainage (ERBD). The stent is not intended to be permanently implanted in the patient. The stent is intended only for short-term implantation.
Product codes (comma separated list FDA assigned to the subject device)
FGE
Device Description
The subject Single Use Billary Drainage Stent V PBD-1030/ 1031/ 1032/ 1033 Stent Series, MAJ-1818/ 1819/ 1820/ 1821/ 1822 Insertion Kit Series and PBD-V630P/ V631P/ V632P Preloaded Stent Series are designed to be used with Olympus endoscopes for Endoscopic Biliary Drainage(ERBD) procedure.
The subject Biliary Stent is placed into the duodenal papilla by using a Guidewire and Pusher Catheter to maintain the flow of bile by indwelling in the duodenal papilla. It is introduced to the biliary duct as follows:
- The user pushes the distal end of the guidewire into the papilla of Vater and 1) advance the guidewire to the target area.
- The user inserts the guide catheter, stent and pusher catheter over the guidewire. 2) The distal portion of the stent is inserted first.
- The user advances the stent until the side flap at its proximal end contacts the 3) papilla of Vater.
- The user withdraw the guide catheter from the pusher catheter to release the 4) stent.
- The user withdraw the pusher catheter from the endoscope. 5)
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
duodenal papilla, biliary duct
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Summary of Non-Clinical Testing
The following non-clinical tests were performed:
-
Biocompatibility
a) Cytotoxicity Test
b) Sensitization Test
c) Intracutaneous Reaction Test
d) Implantation Test
e) Subacute toxicity Test
Systemic toxicity Test f)
g) Chemistry special Test (60 day)
h) Bile solution PH -
Stability
Representative samples of devices were subjected to accelerated and real time ageing. The results of the accelerated age testing demonstrates that the device will be stable for the stated shelf-life. In addition, real time age testing will confirm the results of the accelerated age testing. The test devices were evaluated to ensure they continued to meet their specifications, including flexibility, tensile strength, tensile strength after stent placement, patency and compatibility with the endoscope. -
Bench Testing
Bench testing was performed to compare the flexibility of the stent -
Use of Standards
The following standards were used during the design and validation of the subject devices:
a) ISO 14971, 2007
b) ISO 11135-1, 2007
C) ISO 10993-1, 2003
d) ISO 10993-5, 1999
ISO 10993-6, 1994 e)
f) ISO 10993-10, 2002
ISO 10993-11, 2006 g)
h) ASTM F1980-07
The risk analysis was carried out in accordance with established in-house acceptance criteria based on ISO 14971:2007. The design verifications tests and their acceptance criteria were identified and performed as a result of this risk analysis assessment.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5010 Biliary catheter and accessories.
(a)
Identification. A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap.(b)
Classification. Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
K103478
pg 1 of 3
FEB 2 4 2011
510(k) SUMMARY
PBD-1030/1031/1032/1033 Series, MAJ-1818/1819/1820/1821/1822 Series, PBD-V630P/V631P/V632P Series Single Use Biliary Drainage Stent V
February 23, 2011
1 General Information
| Applicant: | OLYMPUS MEDICAL SYSTEMS CORP.
2951 Ishikawa-cho, Hachioji-shi, Tokyo, Japan 192-8507
Establishment Registration No: 8010047 |
|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Official Correspondent: | Stacy Abbatiello Kluesner, M.S., RAC
Regulatory Affairs & Quality Assurance
Olympus America Inc.
3500 Corporate Parkway
PO Box 610
Center Valley, PA 18034-0610, USA
Phone: 484-896-5405
FAX: 484-896-7128
Email: stacy.kluesner@olympus.com |
| Manufacturer: | Aomori Olympus Co., Ltd.
248-1 Okkonoki 2-chome Kuroishi-shi,
Aomori, Japan 036-0367
Establishment Registration No.: 9614641 |
2 Device Identification
| Device Trade Name: | PBD-1030/1031/1032/1033 Stent Series,
MAJ-1818/1819/1820/1821/1822 Insertion Kit Series,
PBD-V630P/V631P/V632P Preloaded Stent Series
Single Use Biliary Drainage Stent V |
|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name: | Biliary catheter |
| Regulation Number: | 876.5010 |
| Regulation Name: | Biliary catheter and accessories |
| Regulatory Class: | II |
| Classification Panel: | Gastroenterology/Urology |
| Product Code: | FGE |
1
K103478
pg 2 of 3
3 Predicate Device Information
- Device Name: PBD-3Z through 7Z
- 배 OLYMPUS PBD STENTS Common Name:
- I Aomori Olympus Co., Ltd. Manufacturer: 248-1 Okkonoki 2-chome Kuroishi-shi. Aomori, Japan 036-0367 Establishment Registration No .: 9614641
- 510(k) No. #K933200
ব Device Description
The subject Single Use Billary Drainage Stent V PBD-1030/ 1031/ 1032/ 1033 Stent Series, MAJ-1818/ 1819/ 1820/ 1821/ 1822 Insertion Kit Series and PBD-V630P/ V631P/ V632P Preloaded Stent Series are designed to be used with Olympus endoscopes for Endoscopic Biliary Drainage(ERBD) procedure.
The subject Biliary Stent is placed into the duodenal papilla by using a Guidewire and Pusher Catheter to maintain the flow of bile by indwelling in the duodenal papilla. It is introduced to the biliary duct as follows:
- The user pushes the distal end of the guidewire into the papilla of Vater and 1) advance the guidewire to the target area.
- The user inserts the guide catheter, stent and pusher catheter over the guidewire. 2) The distal portion of the stent is inserted first.
- The user advances the stent until the side flap at its proximal end contacts the 3) papilla of Vater.
- The user withdraw the guide catheter from the pusher catheter to release the 4) stent.
- The user withdraw the pusher catheter from the endoscope. 5)
Indications for Use റ
This instrument has been designed to be used with Olympus Endoscopes for endoscopic retrograde biliary drainage (ERBD). The stent is not intended to be permanently implanted in the patient. The stent is intended only for short-term implantation.
Comparison of Technological Characteristics 6
The subject Single Use Biliary Drainage Stent V PBD-1030/1031/1032/1033 Stent Series, MAJ-18181819/1820/1821/1822 Insertion Kit Series and PBD-V630P/V631P/V632P Preloaded Stent Series are basically identical to the predicate biliary stent PBD-62, included in MD-274 except as follows:
- The stent material and a pigment have been changed.
-
- The dimention and shape have been changed.
-
- An accessory device, the Protection Sleeve and straightener have been added.
2
K103478
pg 3 of 3
Summary of Non-Clinical Testing 7
The following non-clinical tests were performed:
-
- Biocompatibility
- a) Cytotoxicity Test
- b) Sensitization Test
- c) Intracutaneous Reaction Test
- d) Implantation Test
- e) Subacute toxicity Test
- Systemic toxicity Test f)
- g) Chemistry special Test (60 day)
- h) Bile solution PH
2) Stability
Representative samples of devices were subjected to accelerated and real time ageing. The results of the accelerated age testing demonstrates that the device will be stable for the stated shelf-life. In addition, real time age testing will confirm the results of the accelerated age testing. The test devices were evaluated to ensure they continued to meet their specifications, including flexibility, tensile strength, tensile strength after stent placement, patency and compatibility with the endoscope.
- Bench Testing
Bench testing was performed to compare the flexibility of the stent
4) Use of Standards
The following standards were used during the design and validation of the subject devices:
- a) ISO 14971, 2007
- b) ISO 11135-1, 2007
- C) ISO 10993-1, 2003
- d) ISO 10993-5, 1999
- ISO 10993-6, 1994 e)
- f) ISO 10993-10, 2002
- ISO 10993-11, 2006 g)
- h) ASTM F1980-07
The risk analysis was carried out in accordance with established in-house acceptance criteria based on ISO 14971:2007. The design verifications tests and their acceptance criteria were identified and performed as a result of this risk analysis assessment.
Conclusion 8
When compared to the predicate device, the PBD-1030/1031/1032/1033 Stent Series MAJ-1818/1819/1820/1821/1822 Insertion Kit Series and PBD-V630P/V631P/V632P Preloaded Stent Series do not incorporate any significant changes in intended use, method of operation, material, or design that could affect the safety or effectiveness of the device.
3
Image /page/3/Picture/0 description: The image shows the seal of the Department of Health & Human Services USA. The seal features a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
Olympus Medical Systems Corp. c/o Stacy Abbatiello Kluesner, M.S., RAC Regulatory Affairs Project Manager · Regulatory Affairs & Ouality Assurance Olympus America. Inc. 3500 Corporate Parkway, P.O. Box 610 CENTER VALLEY PA 18034-0610
FFR 2 4 2011
Re: K103478
Trade/Device Name: PBD-1030/1031/1032/1033 Stent Series, MAJ-1818/1819/1820/1821/1822 Insertion Kit Series, and PBD-V630P/V631P/V632P Preloaded Stent Series Single Use Biliary Drainage Stent V
Regulation Number: 21 CFR $876.5010 Regulation Name: Biliary catheter and accessories Regulatory Class: II Product Code: FGE Dated: November 23, 2010 Received: November 26, 2010
Dear Ms. Kluesner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading,
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related
4
Page 2
adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Hubert H. Humphrey
Herbert P. Lerner, M.D., Director (Acting) Division of Reproductive. Gastro-Renal and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known):
Device Name:
PBD-1030/1031/1032/1033 Series, MAJ-1818/1819/1820/1821/1822 Series PBD-V630P/V631P/V632P Series
Indications For Use:
This instrument has been designed to be used with Olympus Endoscopes for endoscopic retrograde biliary drainage (ERBD). The stent is not intended to be permanently implanted in the patient. The stent is intended only for short-term implantation.
Prescription Use_ (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use_ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Reproductive, Gastro-Renal, and
Urological Devices
| 510(k) Number | K103478 |
|---|---|
| --------------- | --------- |
Page 1 of 1